Remove Biobanking Remove Development Remove DNA Remove Genome Project
article thumbnail

Why genomic healthcare data matters in the development of new therapies 

Drug Discovery World

Genomic healthcare data is critical to identify disease risk, ancestry, traits and response to medicines and aids in the development of new targeted therapies – precision medicines. DDW’s Megan Thomas observes developments of accessibility in this sector and the potential impact. . The origins . The current landscape .

Genome 98
article thumbnail

A new dawn of the genomic age: five areas set to be transformed in 2023

pharmaphorum

In March, the collaborative T2T consortium published the first complete telomere-to-telomere sequence of the human genome, filling in the last 8% of the 3 billion base pairs that make up our DNA. With its already strong genomics foundation, the passing of this bill will cement the UK as a world leader in genomics.

Genome 126
article thumbnail

Q&A: Gene therapy opportunities from long-read sequencing 

Drug Discovery World

To develop safe and effective gene therapies, researchers need confidence that genomic data is both complete and accurate. The key difference between the two technologies is that long-read sequences are more effective at unambiguously determining how all the pieces of a sequenced genome fit together.